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β-Adrenergic receptorsThe aim of this study was to evaluate and compare the effects of early and physiological menopause on car-
diac autonomic parameters in aged female rats. To this end, female Wistar rats (22 and 82 weeks old, N=96)
were divided into 4 groups: Young Sham-operated Rats, Aged Sham-operated Rats, Young Ovariectomised
(OVX) Rats, and Aged OVX Rats. Young Sham-operated and OVX rats were used as controls. The cardiac au-
tonomic parameters were investigated using different approaches: 1) pharmacological evaluation of the au-
tonomic tonus with methylatropine and propranolol; 2) isolated cardiac contractility with β-adrenergic
agonists; and 3) quantiﬁcation of the mRNA and protein level expression of cardiac β-adrenergic receptors.
Among the groups of aged female rats, both the Sham-operated and OVX rats showed higher basal mean ar-
terial pressure and heart rate (HR) values compared to their respective young counterparts. The aged groups
also showed a predominance of the sympathetic autonomic component in the determination of HR, whereas
the young rats showed a vagal predominance. An assessment of cardiac contractility showed that aged
Sham-operated and OVX rats had lower contractile responses following the administration of dobutamine
compared to their respective young counterparts. In addition, the aged groups showed higher mRNA and pro-
tein expression levels of the β1-adrenergic receptors. In conclusion, our results show that haemodynamic
alterations and impairment of the autonomic parameters were similar between the groups of rats subjected
to early and physiological menopause. Moreover, these results seem to be due to the ageing process and not
ovarian hormone deprivation.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Several epidemiological studies have shown that the loss of ovar-
ian function, either spontaneously or surgically induced, before the
age of 40, a condition deﬁned as early menopause (Coulam et al.,
1986), has been associated with an increased risk of myocardial in-
farction, stroke and mortality (Jacobsen et al., 1999; Mondul et al.,
2005; Rivera et al., 2009). In addition, some authors postulate that
this condition, compared to physiological menopause, produces
even greater cardiovascular risks (Van der Schouw et al., 1996;
Atsma et al., 2006; Lobo, 2007).
Based on such information, ovarian hormones seem to have a pro-
tective effect on the cardiovascular system (Miller and Duckles, 2008).
Moreover, the early loss of female hormones seems to be a determinant
for a higher susceptibility to cardiovascular diseases (CVDs). Therefore,
the hypothesis raised is that early surgical removal of the ovaries, whenics and Rehabilitation, School
14049-900, Ribeirão Preto, SP,
3.
).
 OA license.associated with the ageing process, is more devastating for the cardio-
vascular system than when ovaries are preserved during the ageing
process.
The increase in the risk of CVDs with ageing is commonly associat-
ed with impairments in the cardiac autonomic control of both men
and women, and an evaluation of the cardiac sympathetic–vagal bal-
ance is used to predict the cardiovascular risk (Malliani et al., 1991;
Task Force, 1996; La Rovere et al., 2001). In this sense, some studies
have suggested that female hormones are beneﬁcial for cardiovascu-
lar autonomic control (Huikuri et al., 1996; Saleh and Connell, 1999;
Saleh et al., 2000; Dart et al., 2002), even for the autonomic impair-
ments resulting from physiological menopause (Lipsitz et al., 1995;
Huikuri et al., 1996; Davy et al., 1998; Ribeiro et al., 2001; Neves et
al., 2007). However, although the detrimental effects of early meno-
pause on the cardiovascular system have already been addressed in
the literature, no study has investigated the implication of early men-
opause on the autonomic regulation when associated with ageing.
Additionally, changes in other components of the cardiac autonomic
control, such as sensitivity and the density of the cardiac β-adrenergic
receptors, also deserve attention because cardiac responsiveness to
β-adrenergic stimulation is a key factor in the inotropic, chronotropic
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Michel, 1999). Furthermore, studies have shown that in physiological
situations, such as hypertension and heart failure, β-adrenergic signal-
ling is impaired, which can compromise the overall functional capacity
(Atkins et al., 1995; Nagata et al., 2000; Hamdani and Linke, in press). In
this speciﬁc case, studies investigating this aspectwere conducted using
young female rats that were subjected to an ovariectomy without asso-
ciating the results with the ageing process (Thawornkaiwong et al.,
2003; Kam et al., 2004).
Therefore, the objective of the present study was to assess and
compare the effects of early and physiological menopause on cardiac
autonomic parameters with different approaches, including double
pharmacological autonomic blockade, isolated cardiac contractility
using β-adrenergic agonists and quantiﬁcation of mRNA and protein
expression of the cardiac β-adrenergic receptors.
2. Materials and methods
2.1. Animals
The research trials were performed on female Wistar rats supplied
by the Animal Facility of the School of Medicine of Ribeirão Preto,
University of São Paulo, Ribeirão Preto. The rats were housed in a
room with a strictly controlled temperature (23±2 °C) and a 12-h
light/dark cycle with unrestricted access to tap water and standard rat
chow (Nuvilab CR-1, Nuvital, Brazil). All of the experimental protocols
performed in the current study were approved by the Committee on
Animal Research and Ethics of the School of Medicine of Ribeirão
Preto, University of São Paulo (Protocol #198/2008).
2.2. Experimental groups
Ninety-six female Wistar rats (10 weeks old) were initially
subjected to ovariectomy (OVX) or a sham surgery (Sham-operated)
and, after surgical recovery, were divided into four experimental groups
(22 and 82 weeks old): Young Sham-operated Rats (N=24); Aged
Sham-operated Rats (N=24); Young OVX Rats (N=24); and Aged
OVX Rats (N=24). Young Sham-operated and OVX rats were used as
controls.
2.3. Ovariectomy
The rats were anaesthetisedwith tribromoethanol (250 mg/kg, i.p.),
and a small abdominal incisionwasmade. The ovarieswere located, and
a silk thread was tightly tied around the oviduct, including the ovarian
blood vessels. The oviduct was sectioned, and the ovary was removed.
The contralateral ovary was removed in a similar manner. The skin
and muscle walls were then sutured with a silk thread. All of the ani-
mals received prophylactic antibiotic therapy following the surgical
procedures. The Sham-operated rats underwent the same procedure
except for the sectioning of the oviducts and the removal of the ovaries.
The rats were housed individually, and a 2-week post-surgical recovery
period was allowed. Subsequently, the rats were housed in groups of 3
per cage and were allowed to rest for 10 weeks (young groups) or
70 weeks (aged groups) before the experiments began. During the
last 4 weeks, a vaginal smear was collected daily to verify oestrous
cycle regularity in the young Sham-operated group and the absence of
an oestrous cycle (i.e., permanent diestrous state) in the aged
Sham-operated, the young OVX and the aged OVX groups.
2.4. Experimental protocol
2.4.1. Cardiac sympathovagal balance and intrinsic heart rate
At the end of the experimental period, 12 rats per group were
anaesthetised with tribromoethanol (250 mg/kg, i.p.), and polyethyl-
ene catheters were implanted into the right femoral artery and vein.The catheters were tunnelled subcutaneously and exteriorised in
the nape. To prevent the blood from clotting, the catheters were ﬁlled
with heparinised saline solution (500 IU/mL). The rats were then
allowed to recover for 24 h prior to the cardiac sympathovagal as-
sessment protocol, which was carried out without anaesthesia.
The assessment of the inﬂuence of sympathetic and parasympathet-
ic autonomic tone on the HRwas performed by administering propran-
olol (4 mg/kg, i.v.) and methylatropine (5 mg/kg, i.v.), respectively.
After 60 min of basal HR (bHR) recording, methylatropine was injected
into the rats of each group, and the HR was recorded for the following
15 min to assess the effect of vagal blockade on the HR. Propranolol
was then injected in the same rats, and the HR was recorded for
another 15 min to determine the intrinsic HR (iHR). After 24 h, the
methylatropine–propranolol sequencewas reversed to assess the effect
of sympathetic blockade on HR, following the same recording
procedure (15 min each) for each drug, as described previously, to
determine the iHR. The data from the methylatropine–propranolol
and propranolol–methylatropine sequences were pooled to provide
the bHR (before any drugs) and the iHR. In addition, the cardiac
sympathovagal index (SVI) was calculated as the ratio between the
bHR and the iHR (bHR/ iHR). This index expresses the tonic autonomic
balance of the heart, where values above 1 show a predominance of a
sympathetic tone, and values below 1 show a predominance of vagal
tone (Goldberger, 1999).
2.4.2. Cardiac contractility
Isolation and perfusion of the rat heart: At the end of the experi-
mental period, 6 rats per group were anaesthetised and received hep-
arin (5000 UI/kg, i.v.). After a 15-min period, the animals were
sacriﬁced by cervical vessel transection. Following exsanguination,
the hearts were quickly excised and perfused at a constant ﬂow of
10 mL/min with Krebs buffer (in mM: NaCl 118.4, KCl 4.7, CaCl2 2.5,
MgSO47H2O 1.2, NaHCO3 25.0, KH2PO4 1.2, glucose 11.2 and pyruvic
acid 2.0) through a cannula inserted into the aorta. The nutrient solu-
tion was continuously gassed with 95% O2–5% CO2 (pH 7.4) at a pres-
sure of 80 cm of H2O and maintained at 37 °C. The coronary perfusion
pressure was measured using a pressure transducer (HP-1280 C,
Hewlett-Packard). To verify the viability of the preparations, the ven-
tricular contractility was monitored throughout the experiment.
Thus, a metal hook coupled to a force transducer (Statham) was placed
in the heart apex, and an initial tension of 6 g was applied to the organ.
The coronary perfusion pressure and force of contractionwere recorded
using a polygraph (R 611, Beckman). After a 30-min period of
stabilisation, dose–response curves were obtained for dobutamine or
salbutamol. Increasing doses of the drugs (1–100 nmol) were adminis-
trated in a bolus lasting 15 s through amanually sequential application.
The maximum response to dobutamine and salbutamol was induced
with 50 nmol, and thus, this dose was selected for the subsequent
experiments.
2.4.3. RNA isolation and relative quantiﬁcation of mRNA levels by reverse
transcription with subsequent polymerase chain reaction (RT-PCR)
At the end of the experimental period, 6 rats per group were
anaesthetised with tribromoethanol (250 mg/kg, i.p.) and, after a
15-min period, were euthanised by decapitation. The hearts were
quickly removed and then frozen in liquid nitrogenuntil RNA extraction
processing. The frozen hearts were pulverised and homogenised in
Trizol reagent (Invitrogen, Carlsbad, CA). Total RNA was extracted
according to the standard protocol recommended by the manufacturer
and treated with DNase (Invitrogen). Reactions were performed using
the Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen). Brieﬂy,
the reaction conditions were as follows: initial (50 °C, 2 min; 95 °C,
10 min), followed by 40 cycles of denaturation (95 °C, 15 s) and
annealing/extension (60 °C, 1 min) using an Applied Biosystems 7500
Fast Real-time PCR System. Speciﬁc primers were designed based on
GenBank sequences and were used to amplify the gene fragments of
Table 1
Haemodynamic values before and after the autonomic blockers administration in
Sham-operated and OVX rats, young or aged.
Sham-operated OVX
Young
(N=12)
Aged
(N=12)
Young
(N=12)
Aged
(N=12)
Arterial pressure
SAP, mm Hg 110±3 141±3⁎ 114±2 140±3#
DAP, mm Hg 83±3 92±5 85±3 91±4
MAP, mm Hg 92±2 109±2⁎ 95±2 108±3#
Heart rate
Basal HR, bpm 359±2 403±8⁎ 360±3 394±4#
ΔHR after methylatropine,
bpm
77±7 54±7⁎ 78±10 26±5#
ΔMAP after
methylatropine, mm Hg
8±1.5 8±1 9±2 7±1
ΔHR after propranolol, bpm 43±10 100±10⁎ 35±6 90±8#
ΔMAP after propranolol,
mm Hg
10±1 9±2 8±2 9±2
iHR, bpm 366±3 327±6⁎ 365±3 318±5#
SVI 0.98±0.01 1.23±0.04⁎ 0.99±0.01 1.24±0.02#
Values are means±SEM. SAP, systolic arterial pressure; DAP, diastolic arterial
pressure; MAP, mean arterial pressure; HR, heart rate; iHR, intrinsic heart rate; SVI,
sympathovagal index.
⁎ Pb0.05 Young Sham-operated Rats.
# Pb0.05 Young Ovx Rats.
Fig. 1. Heart rate responses to methylatropine (positive values) or propranolol (negative
values) in female rats subjected to Sham or OVX surgery, Young (clear bars) or Aged (grey
bars). The data are expressed as the mean±SEM. ⁎Pb0.05 vs. Young Sham-operated Rats;
#Pb0.05 vs. Young Ovx Rats.
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5-GTTGTAGCAGCGGCGCG-3), β2-adrenergic (forward: 5-ACCTCCTTC
TTGCCTATCCA-3 and reverse: 5-TAGGTTTTCGAAGAAGACCG-3) and
cycloﬁlin (forward: 5-AAGGACTTCATGATCCAGGG-3 and reverse:
5-TGACATCCTTCAGTGGCTTG-3). The ampliﬁcation of cycloﬁlin was
used as the internal control, and the results were presented as the
relative gene expression using the comparative 2−ΔΔCT method
(Livak and Schmittgen, 2001).
2.4.4. Western blot analysis
Proteins (50 mg) extracted from heart were separated by electro-
phoresis on a 10% polyacrylamide gel and transferred to a nitrocellu-
lose membrane. Nonspeciﬁc binding sites were blocked with 1% foetal
bovine serum (FBS) in Tris-buffered saline solution with Tween for
1 h at 24 °C. Membranes were then incubated with adrenergic recep-
tor β1 antibody (1:500, Enzo Life Sciences, Inc., Farmingdale, NY, USA)
overnight at 4 °C. After incubation with secondary antibody, analyses
of the bands were performed with software (ImageJ®) that evaluates
the density proﬁle extraction and band analysis. Results were normal-
ized to β-actin protein and expressed as arbitrary units.
2.5. Drugs
Atropine methyl nitrate, dobutamine, propranolol hydrochloride,
salbutamol and tribromoethanol were purchased from Sigma Chemical
Co. (St. Louis, MO, USA).
2.6. Statistical analysis
The data are expressed asmean±standard error of themean (SEM).
A two-way ANOVA followed by Tukey's multiple comparison test was
performed to evaluate the effects of ovariectomy (Sham-operated ver-
sus OVX) and age (Young versus Aged). The differences were consid-
ered signiﬁcant at Pb0.05. All statistical tests were performed with
SigmaStat 3.5 software (Systat Software Inc., San Jose, CA, USA).
3. Results
3.1. Haemodynamic values
The aged female Sham-operated and OVX rats showed higher basal
HR values, systolic arterial pressure (SAP) and mean arterial pressure
(MAP) compared to their respective young counterparts (Table 1).
3.2. Cardiac sympathovagal balance
Fig. 1 and Table 1 show the effects of double pharmacological auto-
nomic blockade onHR in all of the studied groups. The administration of
methylatropine in the groups of young female Sham-operated and OVX
rats promoted greater changes in HR compared to propranolol, thereby
indicating a predominance of the vagal autonomic component in the
determination of the basal HR. Moreover, an inverse effect was ob-
served in the groups of aged Sham-operated and OVX rats indicating a
predominance of a sympathetic autonomic component in the determi-
nation of the basal HR. These results were conﬁrmed by the SVI. Table 1
also shows that the aged groups presented a similar reduction in iHR
compared to their respective young counterparts. Additionally, the
administration of methylatropine and propranolol promoted a small
increase in MAP in all groups studied.
3.3. Effect of dobutamine and salbutamol on cardiac contractility
Table 2 shows that the basal cardiac contractilitywas similar between
the studied groups. The administration of dobutamine (β1-adrenergic
agonist, 0.5–50 nmol) and salbutamol (β2-adrenergic agonist, 0.5–
50 nmol) induced a dose-dependent contractile response in all of thegroups (Fig. 2A and C). However, in the groups of aged Sham-operated
and OVX rats, dobutamine induced a less dose-dependent contractile re-
sponse, as well as a reducedmaximal contraction (Fig. 2A and B). In turn,
the contractile response to salbutamol was not different between the
studied groups (Fig. 2D).
3.4. mRNA expression of cardiac β-adrenergic receptors
Table 2 shows the relative mRNA expression quantiﬁcation of the
cardiac β-adrenergic receptors. The groups of aged Sham-operated
and OVX rats presented a higher expression of the β1-adrenergic re-
ceptor when compared to their respective young counterparts. In
turn, the expression of the β2-adrenergic receptors was similar in all
of the groups studied.
3.5. Protein expression
Fig. 3 shows the protein expression of cardiac β1-adrenergic
receptors. The groups of aged Sham-operated and OVX rats presented
Table 2
Values of maximum contractile response to cardiac β-adrenergic agonists, dobutamine
and salbutamol, and mRNA expression of the cardiac β-adrenergic receptors in
Sham-operated and OVX rats, young and aged.
Sham-operated OVX
Young
(N=6)
Aged
(N=6)
Young
(N=6)
Aged
(N=6)
Basal contractility (g) 7.7±0.4 7.9±0.3 7.4±0.7 7.2±0.4
Dobutamine (β1-adrenergic)
Max. response (50 nmol), g 5.8±0.6 3.28±0.2⁎ 5.7±0.6 3.4±0.3#
Salbutamol (β2-adrenergic)
Max. response (50 nmol), g 4.4±0.7 2.7±0.2 3.9±0.4 3.3±0.2
RNAm expression
β1 (2−ΔΔCT) 1.07±0.1 3.7±0.6⁎ 0.99±0.1 3.8±0.8#
β2 (2−ΔΔCT) 1.02±0.08 1.03±0.2 0.99±0.05 0.97±0.07
Values are means±SEM.
⁎ Pb0.05 Young Sham-operated Rats.
# Pb0.05 Young Ovx Rats.
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pared to their respective young counterparts.4. Discussion
The present study has shown that groups of aged female Sham-
operated and OVX rats had similar impairments in all of the parame-
ters evaluated, presenting an increase in the basal values of MAP and
HR, an increase in the sympathetic autonomic inﬂuence on the deter-
mination of basal HR, a decrease in the contractile responses to
dobutamine and an overexpression of mRNA and protein level of
the cardiac β1-adrenergic receptors.Fig. 2. (A) Dose–response curve and (B) maximum contractile response (50 nmol) induced
(50 nmol) induced by salbutamol in the Sham-operated and OVX Wistar Rats, Young and A
#Pb0.05 Young Ovx Rats.The high values of MAP observed in the groups of aged Sham-
operated and OVX were the result of an SAP increase, which is usually
associated with the ageing process and mainly causes a reduction in
arterial compliance and an increase in vascular wall thickness (Tanaka
et al., 2000; Sugawara et al., 2004; Hart et al., 2011). However, some
authors have suggested that ovarian deprivation could also promote
hypertension. This statement was based on studies that showed high
levels of MAP in young ovariectomised rats (Hernández et al., 2000;
Irigoyen et al., 2005; Flues et al., 2010), however, our results do not sup-
port this notion.
With regard to the basal HR increase, a ﬁnding also observed only in
the groups of aged rats, our results suggest that a possible cause might
be disorders observed in cardiac autonomic balance. This statement is
based on the results obtained after double pharmacological blockade
with methylatropine and propranolol. In this protocol, we have identi-
ﬁed that the sympathetic autonomic component had a greater inﬂuence
on the heart, which may account for the basal HR increase, as the iHR
was reduced. Moreover, other studies corroborate our ﬁndings by
showing both increased plasma levels of catecholamine (Rubin et al.,
1982; Esler et al., 1995) and peripheral sympathetic nervous activity
(Iwase et al., 1991; Ng et al., 1993) with ageing.
In the present study, we also investigated the effect of ovarian
hormone deprivation on the interface between sympathetic stimula-
tion and the heart. According to the literature, the heart expresses β1,
β2, and β3-adrenergic receptors, with the former being predominant
over the latter at a relative ratio of β1/ β2 in the normal myocardium
of approximately 70:30% in the atria and 80:20% in the ventricles
(Brodde, 1991, 1993; Bylund et al., 1994; Brodde and Michel, 1999),
both responsible for the increase in HR and cardiac contractility
(Wallukat, 2002). Contrary to the β1 and β2-adrenergic receptors,
the β3-adrenergic receptors seem to mediate negative inotropicby dobutamine and (C) dose–response curve and (D) maximum contractile response
ged. The data are expressed as the mean±SEM. ⁎Pb0.05 Young Sham-operated Rats;
Fig. 3. On the top (A) includes representative immunoblots for β1-adrenergic receptor
and β-actin expression in the hearts of all studied groups. On the bottom (B), correspond-
ing bar graphs demonstrate β1-adrenergic expression. Values expressed in arbitrary units
are mean±SEM (n=6) and were normalized by β-actin protein expression. ⁎Pb0.05
Young Sham-operated Rats; #Pb0.05 Young Ovx Rats.
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Germack and Dickenson, 2006).
Evaluation of cardiac contractility showed that the groups of aged
rats, regardless of the type of menopause studied (i.e., early or phys-
iological), had a similar reduction in the myocardial contractile
response when the β1-adrenergic receptors were stimulated, but
not following stimulation of the β2-adrenergic receptors, when com-
pared to groups of young Sham-operated and OVX rats. In addition,
we have also observed that these animals overexpressed mRNA and
protein level of the cardiac β1-adrenergic receptors. The causes of
these ﬁndings are uncertain; however, several studies showed that
the cardiac response to β-adrenergic stimulation decreases with age
(Lakatta et al., 1975; Sakai et al., 1992; Xiao and Lakatta, 1992;
Marin, 1995; Davies et al., 1996; Hardouin et al., 1997), thus corrobo-
rating our results. However, a reduction in cardiac contractility as a
result of the ageing process is frequently associated with a decreased
expression of the β1-adrenergic receptors due to a reduction in either
the density or the mRNA expression (Hardouin et al., 1997; Xiao et al.,
1998), which is a result different from ours. With regard to the
β2-adrenergic receptors, no difference was found between the groups
studied, a ﬁnding also reported by other authors (Cerbai et al., 1995).
It is possible that the changes found in the expression of
β1-adrenergic receptors are the result of an increase in sympathetic
activity in an attempt to compensate for the progressive loss of cardi-
ac contractility. Nevertheless, chronic exposure of the heart to high
concentrations of catecholamines, released by the sympathetic ner-
vous terminals and the adrenal gland, could produce other cardiac
changes, resulting in a continuous elevation of the sympathetic
tonus and a progressive deterioration of structure and cardiac func-
tion (Post et al., 1999; Port and Bristow, 2001; Brum et al., 2002;
Lohse et al., 2003). In addition, studies in transgenic mice showed
that overexpression of the β1-adrenergic receptors in the heart
could lead to a short-term improvement of cardiac function, but it
might also be harmful long-term and may promote cardiomyocyte
hypertrophy followed by ﬁbrosis and heart failure (Engelhardt et al.,
1999; Bisognano et al., 2000). Finally, the causes and mechanisms
involved in the changes of cardiac contractility and expression of
the β-adrenergic receptors found in the present study need to be
further investigated in the future, including the participation of ovar-
ian hormones in this process.
In conclusion, our ﬁndings showed no signiﬁcant differences be-
tween early and physiological menopause in the protocols evaluated.
Furthermore, the hypertension and tachycardia associated withimpairment in the autonomic parameters were mainly due to the
ageing process.
Acknowledgements
We thank Orlando Mesquita Jr. for technical assistance.
This study was supported by the FAPESP (2008/10929-9) and
CNPq research grants.
References
Atkins, F.L., Bing, O., Dimauro, P.G., Conrad, C.H., Robinson, K.G., Brooks,W.W., 1995. Mod-
ulation of left and right ventricularβ-adrenergic receptors from spontaneously hyper-
tensive rats with left ventricular hypertrophy and failure. Hypertension 26, 78–82.
Atsma, F., Bartelink, M.L.E.L., Grobbee, D.E., van der Schouw, Y.T., 2006. Postmenopausal
status and early menopause as independent risk factors for cardiovascular disease:
a meta-analysis. Menopause 13 (2), 265–279.
Bisognano, J.D., Weinberger, H.D., Bohlmeyer, T.J., Pende, A., Raynolds, M.V., Sastravaha,
A., Roden, R., Asano, K., Blaxall, B.C., Wu, S.C., Communal, C., Singh, K., Colucci, W.,
Bristow, M.R., Port, D.J., 2000. Myocardial-directed overexpression of the human
β1-adrenergic receptor in transgenic mice. J. Mol. Cell. Cardiol. 32, 817–830.
Brodde, O.E., 1991. Beta 1- and beta 2-adrenoceptors in the human heart: properties,
function, and alterations in chronic heart failure. Pharmacol. Rev. 43 (2), 203–242.
Brodde, O.E., 1993. Beta-adrenoceptors in cardiac disease. Pharmacol. Ther. 60 (3),
405–430.
Brodde, O.E., Michel, M.C., 1999. Adrenergic and muscarinic receptors in the human
heart. Pharmacol. Rev. 51, 651–689.
Brum, P.C., Kosek, J., Patterson, A., Bernstein, D., Kobilka, B., 2002. Abnormal cardiac
function associated with sympathetic nervous system hyperactivity in mice. Am.
J. Physiol. Heart Circ. Physiol. 283 (5), H1838–H1845.
Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P.,
Molinoff, P.B., Ruffolo Jr., R.R., Trendelenburg, U., 1994. International Union of
Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46, 121–136.
Cerbai, E., Guerra, L., Varani, K., Barbieri, M., Borea, P.A., Mugelli, A., 1995. Beta-
adrenoceptor subtypes in young and old rat ventricular myocytes: a combined
patch-clamp and binding study. Br. J. Pharmacol. 116 (2), 1835–1842.
Coulam, C.B., Adamson, S.C., Annagers, J.F., 1986. Incidence of premature ovarian fail-
ure. Obstet. Gynecol. 67, 604–606.
Dart, A.M., Du, X.J., Kingwell, B.A., 2002. Gender, sex hormones and autonomic nervous
control of the cardiovascular system. Cardiovasc. Res. 53, 678–687.
Davies, C.H., Ferrara, N., Harding, S.E., 1996. Beta-adrenoceptor function changes with
age of subject in myocytes from non-failing human ventricle. Cardiovasc. Res. 31,
152–156.
Davy, K.P., DeSouza, C.A., Jones, P.P., Seals, D.R., 1998. Elevated heart rate variability in
physically active young and older adult women. Clin. Sci. 94 (6), 579–584.
Devic, E., Xiang, Y., Gould, D., Kobilka, B., 2001. Beta-adrenergic receptor subtype-
speciﬁc signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor
knockout mice. Mol. Pharmacol. 60 (3), 577–583.
Engelhardt, S., Hein, L., Wiesmann, F., Lohse, M.J., 1999. Progressive hypertrophy and
heart failure in beta1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci.
U. S. A. 96 (12), 7059–7064.
Esler, M.D., Turner, A.G., Kaye, D.M., Thompson, J.M., Kingwell, B.A., Morris, M.,
Lambert, G.W., Jennings, G.L., Cox, H.S., Seals, D.R., 1995. Aging effects on human
sympathetic neuronal function. Am. J. Physiol. 268 (1 Pt 2), R278–R285.
Flues, K., Paulini, J., Brito, S., Sanches, I.C., Consolim-Colombo, F., Irigoyen, M.C., De Angelis,
K., 2010. Exercise training associated with estrogen therapy induced cardiovascular
beneﬁts after ovarian hormones deprivation. Maturitas 65 (3), 267–271.
Gauthier, C., Langin, D., Balligand, J.L., 2000. Beta3-adrenoceptors in the cardiovascular
system. Trends Pharmacol. Sci. 21, 426–431.
Germack, R., Dickenson, J.M., 2006. Induction of beta3-adrenergic receptor functional
expression following chronic stimulation with noradrenaline in neonatal rat
cardiomyocytes. J. Pharmacol. Exp. Ther. 316, 392–402.
Goldberger, J.J., 1999. Sympathovagal balance: how should wemeasure it? Am. J. Physiol.
276 (4 Pt 2), H1273–H1280.
Hamdani, N., Linke, W.A., in press. Alteration of the beta-adrenergic signaling pathway
in human heart failure. Curr. Pharm. Biotechnol. (Electronic publication ahead of
print).
Hardouin, S., Mansier, P., Bertin, B., Dakhly, T., Swynghedauw, B., Moalic, J.M., 1997.
beta-Adrenergic and muscarinic receptor expression are regulated in opposite
ways during senescence in rat left ventricle. J. Mol. Cell. Cardiol. 29 (1), 309–319.
Hart, E.C., Charkoudian, N., Wallin, B.G., Curry, T.B., Eisenach, J., Joyner, M.J., 2011.
Sex and ageing differences in resting arterial pressure regulation: the role of the
β-adrenergic receptors. J. Physiol. (Lond.) 589 (Pt 21), 5285–5297.
Hernández, I., Delgado, J.L., Díaz, J., Quesada, T., Teruel, M.J., Llanos, M.C., Carbonell, L.F.,
2000. 17β-Estradiol prevents oxidative stress and decreases blood pressure in ovari-
ectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1599–R1605.
Huikuri, H.V., Pikkujamsa, S.M., Airaksinen, K.E., Ikaheimo, M.J., Rantala, A.O., Kauma,
H., Lilja, M., Kesaniemi, Y.A., 1996. Sex-related differences in autonomic modula-
tion of heart rate in middle-aged subjects. Circulation 94, 122–125.
Irigoyen, M.C., Paulini, J., Flores, L.J., Flues, K., Bertagnolli, M., Moreira, E.D., Consolim-
Colombo, F., Belló-Klein, A., De Angelis, K., 2005. Exercise training improves baro-
reﬂex sensitivity associated with oxidative stress reduction in ovariectomized
rats. Hypertension 46 (4), 998–1003.
41G.C.S.V. Tezini et al. / Autonomic Neuroscience: Basic and Clinical 174 (2013) 36–41Iwase, S., Mano, T., Watanabe, T., Saito, M., Kobayashi, F., 1991. Age-related changes of
sympathetic outﬂow to muscles in humans. J. Gerontol. 46 (1), M1–M5.
Jacobsen, B.K., Knutsen, S.F., Fraser, G.E., 1999. Age at natural menopause and total
mortality and mortality from ischemic heart disease: the Adventist Health Study.
J. Clin. Epidemiol. 52 (4), 303–307.
Kam, K.W., Qi, J.S., Chen, M., Wong, T.M., 2004. Estrogen reduces cardiac injury and ex-
pression of beta1-adrenoceptor upon ischemic insult in the rat heart. J. Pharmacol.
Exp. Ther. 309 (1), 8–15.
La Rovere, M.T., Pinna, G.D., Hohnloser, S.H., Marcus, F.I., Mortara, A., Nohara, R., Bigger
Jr., J.T., Camm, A.J., Schwartz, P.J., ATRAMI Investigators, Autonomic Tone and
Reﬂexes After Myocardial Infarcton, 2001. Baroreﬂex sensitivity and heart rate
variability in the identiﬁcation of patients at risk for life-threatening arrhythmias:
implications for clinical trials. Circulation 103 (16), 2072–2077.
Lakatta, E.G., Gerstenblith, G., Angell, C.S., Shock, N.W., Weisfeldt, M.L., 1975. Diminished
inotropic response of aged myocardium to catecholamines. Circ. Res. 36, 262–269.
Lipsitz, L.A., Connelly, C.M., Kelley-Gagnon, M., Kiely, D.K., Morin, R.J., 1995. Effects of
chronic estrogen replacement therapy on beat-to-beat blood pressure dynamics
in healthy postmenopausal women. Hypertension 26, 711–715.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-
time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods 25 (4),
402–408.
Lobo, R.A., 2007. Surgical menopause and cardiovascular risks. Menopause 14 (3 Pt 2),
562–566.
Lohse, M.J., Engelhardt, S., Eschenhagen, T., 2003. What is the role of beta-adrenergic
signaling in heart failure? Circ. Res. 93 (10), 896–906.
Malliani, A., Pagani, M., Lombardi, F., Cerutti, S., 1991. Cardiovascular neural regulation
explored in the frequency domain. Circulation 84, 482–492.
Marin, J., 1995. Age-related changes in vascular responses: a review. Mech. Ageing Dev.
14, 71–114.
Miller, V.M., Duckles, S.P., 2008. Vascular actions of estrogens: functional implications.
Pharmacol. Rev. 60, 210–241.
Mondul, A.M., Rodriguez, C., Jacobs, E.J., Calle, E.E., 2005. Age at natural menopause and
cause-speciﬁc mortality. Am. J. Epidemiol. 162 (11), 1089–1097.
Nagata, K., Communal, C., Lim, C.C., Jain, M., Suter, T.M., Eberli, F.R., Satoh, N., Colucci,
W.S., Apstein, C.S., Liao, R., 2000. Altered beta-adrenergic signal transduction in
nonfailing hypertrophied myocytes from Dahl salt-sensitive rats. Am. J. Physiol.
Heart Circ. Physiol. 279 (5), H2502–H2508.
Neves, V.F., Silva de Sá, M.F., Gallo Jr., L., Catai, A.M., Martins, L.E., Crescêncio, J.C., Perpétuo,
N.M., Silva, E., 2007. Autonomic modulation of heart rate of young and postmeno-
pausal women undergoing estrogen therapy. Braz. J. Med. Biol. Res. 40 (4), 491–499.
Ng, A.V., Callister, R., Johnson, D.G., Seals, D.R., 1993. Age and gender inﬂuence muscle
sympathetic nerve activity at rest in healthy humans. Hypertension 21 (4), 498–503.Port, J.D., Bristow, M.R., 2001. Altered beta-adrenergic receptor gene regulation and
signaling in chronic heart failure. J. Mol. Cell. Cardiol. 33 (5), 887–905.
Post, S.R., Hammond, H.K., Insel, P.A., 1999. Beta-adrenergic receptors and receptor
signaling in heart failure. Annu. Rev. Pharmacol. Toxicol. 39, 343–360.
Ribeiro, T.F., Azevedo, G.D., Crescêncio, J.C., Marães, V.R., Papa, V., Catai, A.M., Verzola,
R.M., Oliveira, L., Silva de Sá, M.F., Gallo Júnior, L., Silva, E., 2001. Heart rate variabil-
ity under resting conditions in postmenopausal and young women. Braz. J. Med.
Biol. Res. 34 (7), 871–877.
Rivera, C.M., Grossardt, B.R., Rhodes, D.J., Brown Jr., R.D., Roger, V.L., Melton III, L.J.,
Rocca, W.A., 2009. Increased cardiovascular mortality after early bilateral oopho-
rectomy. Menopause 16 (1), 15–23.
Rubin, P.C., Scott, P.J., Mclean, K., Reid, J.L., 1982. Noradrenaline release and clearance in
relation to age and blood pressure in man. Eur. J. Clin. Invest. 12 (2), 121–125.
Sakai, M., Danziger, R.S., Xiao, R.P., Spurgeon, H.A., Lakatta, E.G., 1992. Contractile
response of individual cardiac myocytes to norepinephrine declines with senes-
cence. Am. J. Physiol. Heart Circ. Physiol. 262, H184–H189.
Saleh, M.C., Connell, B.J., Saleh, T.M., 2000. Autonomic and cardiovascular reﬂex re-
sponses to central estrogen injection in ovariectomized female rats. Brain Res.
879 (1–2), 105–114.
Saleh, T.M., Connell, B.J., 1999. Centrally mediated effect of 17-beta-estradiol on para-
sympathetic tone in male rats. Am. J. Physiol. 276 (2 Pt 2), R474–R481.
Sugawara, J., Inoue, H., Hayashi, K., Yokoi, T., Kono, I., 2004. Effect of low-intensity aerobic
exercise training on arterial compliance in postmenopausal women. Hypertens. Res.
27 (12), 897–901.
Tanaka, H., Dinenno, F.A., Monahan, K.D., Clevenger, C.M., Desouza, C.A., Seals, D.R.,
2000. Aging, habitual exercise, and dynamic arterial compliance. Circulation 102
(11), 1270–1275.
Task Force of the European Society of Cardiology and the North American Society of
Pacing and Electrophysiology, 1996. Heart rate variability: standards of measure-
ment, physiological interpretation and clinical use. Circulation 93, 1043–1065.
Thawornkaiwong, A., Preawnim, S., Wattanapermpool, J., 2003. Upregulation of beta1-
adrenergic receptors in ovariectomized rat hearts. Life Sci. 72, 1813–1824.
van der Schouw, Y.T., van der Graaf, Y., Steyerberg, E.W., Eijkemans, J.C., Banga, J.D.,
1996. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347
(9003), 714–718.
Wallukat, G., 2002. The beta-adrenergic receptors. Herz 27 (7), 683–690.
Xiao, R.P., Lakatta, E.G., 1992. Deterioration of beta-adrenergic modulation of cardio-
vascular function with aging. Ann. N. Y. Acad. Sci. 673, 293–310.
Xiao, R.P., Tomhave, E.D., Wang, D.J., Ji, X., Boluyt, M.O., Cheng, H., Lakatta, E.G., Koch,
W.J., 1998. Age-associated reductions in cardiac beta1- and beta2-adrenergic
responses without changes in inhibitory G proteins or receptor kinases. J. Clin.
Invest. 101 (6), 1273–1282.
